Page last updated: 2024-10-26

dipyridamole and Hypothyroidism

dipyridamole has been researched along with Hypothyroidism in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomanek, RJ1
Barlow, PA1
Connell, PM1
Chen, Y1
Torry, RJ1

Other Studies

1 other study available for dipyridamole and Hypothyroidism

ArticleYear
Effects of hypothyroidism and hypertension on myocardial perfusion and vascularity in rabbits.
    The American journal of physiology, 1993, Volume: 265, Issue:5 Pt 2

    Topics: Animals; Arterioles; Blood Pressure; Body Weight; Coronary Circulation; Coronary Vessels; Dipyridamo

1993